Suppr超能文献

[前列腺癌细针穿刺]

[Fine needle puncture of prostatic cancer].

作者信息

Studer U, Kraft R, Wiedmer-Bridel J

出版信息

Schweiz Med Wochenschr. 1982 Jun 5;112(23):810-6.

PMID:7100877
Abstract

Before commencing treatment for prostatic cancer the diagnosis must be confirmed by microscopic examination of prostatic tissue. Fine-needle aspiration biopsy by an experienced clinician is as accurate as the more invasive Tru-cut or Vim-Silverman needle biopsies. It involves fewer complications such as hemorrhage or infection, and does not require anesthesia. From 1971 to 1981 we performed more than 2300 fine needle biopsies including 2209 in outpatients. Only 4 patients (0.18%) needed hospitalizing for severe complications. Where the clinical examination prompts suspicion of prostatic cancer and the first fine needle biopsy is negative, the procedure should be repeated. When repeated aspirations were performed only 4 (2%) false negative cytologies were found out of 195 patients in whom prostatic cancer was clinically evident and confirmed by either cytology or histology. False negative cytological results are usually due to sampling errors by the physician rather than interpretation by the cytologist. The histology was false negative in 11.5% of 200 cases and this was due to failure of transurethral resection to reach a focal carcinoma situated in the capsule or sphincter region. Identical histological and cytological grading was found in 66% of the 168 cases where both investigations were positive. If a difference of one grade was accepted, the concurrence is 99%. The results of fine needle biopsy depend on the skill of the clinician in obtaining the right sample, and especially on the experience of the cytologist in its interpretation.

摘要

在开始前列腺癌治疗之前,必须通过前列腺组织的显微镜检查来确诊。由经验丰富的临床医生进行细针穿刺活检,其准确性与侵入性更强的Tru-cut或Vim-Silverman针吸活检相同。它涉及的并发症较少,如出血或感染,且无需麻醉。1971年至1981年期间,我们进行了2300多次细针活检,其中包括2209例门诊患者的活检。只有4例患者(0.18%)因严重并发症需要住院治疗。如果临床检查提示怀疑患有前列腺癌,而首次细针活检结果为阴性,则应重复该检查。在195例临床诊断为前列腺癌且经细胞学或组织学确诊的患者中,仅进行重复穿刺时,发现4例(2%)为假阴性细胞学结果。假阴性细胞学结果通常是由于医生采样错误,而非细胞学家的解读问题。在200例病例中,有11.5%的组织学检查结果为假阴性,这是由于经尿道切除术未能触及位于包膜或括约肌区域的局灶性癌。在168例组织学和细胞学检查均为阳性的病例中,66%的病例组织学和细胞学分级相同。如果允许相差一个等级,则一致性为99%。细针活检的结果取决于临床医生获取正确样本的技能,尤其取决于细胞学家对样本解读的经验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验